sign in sign up
<<
Home , Camazepam, Clortermine, Drotebanol, Mebutamate, Nabilone, Parahexyl

Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

1 CONTROLLED SUBSTANCES BOARD CSB 2.02

Chapter CSB 2

ADDITIONS TO SCHEDULES IN SS. 961.14, 961.16, 961.18, 961.20 AND 961.22, STATS.

CSB 2.01 Addition of to schedule II. CSB 2.44 Addition of to schedule II. CSB 2.02 Addition of , , clortermine, mazin- CSB 2.45 Addition of AB−FUBINACA and ADB−PINACA to schedule I. dol, and to schedule III. CSB 2.46 Addition of acetyl to schedule I. CSB 2.03 Addition of to schedule IV. CSB 2.47 Addition of AH−7921 to schedule I. CSB 2.04 Addition of , , and to schedule CSB 2.48 Addition of to schedule IV. II; retention of certain forms of amobarbital, pentobarbital and CSB 2.49 Addition of U−47700 to schedule I. secobarbital in schedule III. CSB 2.50 Addition of AB−CHMINACA, AB−PINACA and THJ−2201 to CSB 2.05 Addition of to schedule I. schedule I. CSB 2.06 Addition of to schedule III. CSB 2.51 Addition of MAB−CHMINACA to schedule I. CSB 2.07 Transfer of hydrochloride form of from schedule I to sched- CSB 2.52 Addition of 4−MePPP and a−PBP to schedule I. ule II. CSB 2.53 Scheduling of acryl fentanyl. CSB 2.08 Addition of to schedule II, addition of and CSB 2.54 Addition of oral solutions containing to schedule II. to schedule IV. CSB 2.55 Addition of 5F−ADB, 5F−AMB, ADB−FUBINACA, MDMB− CSB 2.09 Additions to schedules IV and I. CHMICA and MDMB−FUBINACA to schedule I. CSB 2.10 Addition of to schedule I. CSB 2.56 Addition of 4−fluoroisobutyryl fentanyl to schedule I. CSB 2.11 Renumbering and addition to schedule IV of diethylpropion and CSB 2.57 Scheduling of cyclopropyl fentanyl. . CSB 2.58 Exclusion of . CSB 2.13 Addition of to schedule IV. CSB 2.59 Addition of ortho−fluorofentanyl to schedule I. CSB 2.14 Addition of to schedule IV. CSB 2.60 Addition of FUB−AMB to schedule I. CSB 2.15 Addition of to schedule I; removal of from CSB 2.61 Addition of MT−45 to schedule I. schedule V; addition of to schedule IV. CSB 2.62 Addition of para−chloroisobutyryl fentanyl to schedule I. CSB 2.16 Transfer of from schedule I to schedule II. CSB 2.63 Addition of NM2201, 5F−AB−PINACA, 4−CN−CUMYL−BUTI- CSB 2.17 Addition of to schedule V; transfer of methaqualone NACA, MMB−CHMICA and 5F−CUMYL−P7AICA to schedule from schedule II to schedule I; transfer of dronabinol from sched- I. ule I to schedule II. CSB 2.64 Addition of N−Ethylpentylone to schedule I. CSB 2.18 Addition of 3,4−methylenedioxymethamphetamine to schedule I. CSB 2.65 Addition of approved to schedule V. CSB 2.19 Additions, deletions and transfers to statutory schedules. CSB 2.66 Addition of 5F−EDMB−PINACA, 5F−MDMB−PICA, FUB− CSB 2.20 Addition of beta−hydroxy−3−methylfentanyl to schedule I. AKB48, 5F−CUMYL−PINACA, and FUB−144 to schedule I. CSB 2.21 Additions, deletions, corrections, transfers, and amendments to CSB 2.67 Addition of Brexanolone and to schedule IV. schedules. CSB 2.68 Addition of N−Ethylhexedrone, a−PHP, 4−MEAP, MPHP, PV8 and CSB 2.22 Additions to drug schedules. CSB 2.23 Additions and amendments to drug schedules. 4−chloro−a−PVP to schedule I. CSB 2.24 Addition of to schedule IV. CSB 2.69 Addition of to schedule II. CSB 2.25 Addition of to schedule II; transfer of dronabinol from CSB 2.70 Scheduling 4F−MDMB−BINACA and MMB−FUBICA. schedule II to schedule III; addition of , , CSB 2.71 Addition of lasmiditan to schedule V. , and to schedule IV; spelling cor- CSB 2.72 Scheduling of and 1P−LSD. rection of . CSB 2.73 Addition of cenobamate to schedule V. CSB 2.26 Addition of to schedule II. CSB 2.74 Addition of to schedule IV. CSB 2.28 Addition of to schedule IV. CSB 2.75 Exclusion of approved cannabidiol drugs from schedule I. CSB 2.29 Transfer of buprenorphine from schedule V to schedule III. CSB 2.76 Addition of norfentanyl to schedule II. CSB 2.30 Addition of gamma−hydroxybutyric acid to schedule III. CSB 2.77 Scheduling of . CSB 2.31 Addition of 2,5 dimethoxy−4−(n)− propylthiophenethylamine CSB 2.78 Addition of crotonyl fentanyl to schedule I. (−T−7) to schedule I. CSB 2.79 Addition of to schedule IV. CSB 2.32 Addition of N− (BZP) to schedule I. CSB 2.80 Addition of to schedule II. CSB 2.33 Addition of −methyltryptamine (AMT) to schedule I. CSB 2.81 Addition of to schedule I. CSB 2.34 Addition of 5−methoxy−N, N− (5−MeO− CSB 2.82 Addition of Serdexmethylphenidate to schedule IV. DIPT). CSB 2.83 Addition of ten (10) fentanyl−related substances to schedule I. CSB 2.35 Addition of to schedule II. CSB 2.84 Addition of to schedule IV. CSB 2.36 Addition of to schedule IV. CSB 2.85 Excluding 6−beta−naltrexol from schedule II. CSB 2.37 Rescheduling of combination products. CSB 2.86 Addition of to schedule IV. CSB 2.38 Addition of to schedule IV. CSB 2.87 Addition of to schedule III. CSB 2.39 Exclusion of . CSB 2.88 Addition of to schedule V. CSB 2.40 Exclusion of [123I]. CSB 2.89 Addition of perampanel to schedule III. CSB 2.41 Scheduling of beta−hydroxythiofentanyl and butyryl fentanyl. CSB 2.90 Transfer of 1−phenylcyclohexylamine and 1−piperidinocyclo- CSB 2.42 Scheduling of furanyl fentanyl. hexanecarbonitrile, immediate precursors to , also CSB 2.43 Addition of brivaracetam to schedule V. known as PCP, from Schedule I to schedule II.

CSB 2.01 Addition of methaqualone to schedule II. (2m) Any material, compound, mixture, or preparation which The substance known as methaqualone is hereby added to s. contains any quantity of the following substances having a poten- 161.16, Stats., schedule II in sub. (6) which subsection is hereby tial for abuse associated with a effect on the central ner- created. vous system: Note: See Chapter 206, Laws of 1981 sections 29 and 31. (a) Benzphetamine History: Cr. Register, June, 1973, No. 210, eff. 7−1−73. (b) Chlorphentermine CSB 2.02 Addition of benzphetamine, chlorphen- (c) Clortermine termine, clortermine, , and phendimetrazine to (d) Mazindol schedule III. The substances known as benzphetamine, chlor- (e) Phendimetrazine phentermine, clortermine, mazindol, and phendimetrazine are History: Cr. Register, October, 1973, No. 214, eff. 11−1−73. hereby added to s. 161.18, Stats., schedule III in sub. (2m) (a), (b), (c), (d) and (e) respectively, which subsections are created to read:

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published. Register July 2021 No. 787 Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

CSB 2.03 WISCONSIN ADMINISTRATIVE CODE 2

CSB 2.03 Addition of fenfluramine to schedule IV. (d) Concentrate of poppy straw (the crude extract of Poppy The substance known as fenfluramine is hereby added to s. Straw in either liquid, solid or powder form which contains the 161.20, Stats., schedule IV in sub. (2m) (a), which subsection is phenanthrene of the poppy). hereby created to read: (2) Paragraph (n) of sub. (2) of s. 161.20, Stats., schedule IV (2m) Any material, compound, mixture, or preparation which is hereby created to read: contains any quantity of the following substances having a poten- (n) Mebutamate tial for abuse associated with a stimulant effect on the central ner- (3) Paragraph (b) of sub. (2m) of s. 161.20, Stats., schedule IV vous system: is hereby created to read: (a) Fenfluramine: (b) Pemoline: Note: See Chapter 206, Laws of 1981 section 47. Note: See Chapter 206, Laws of 1981 sections 20, 22 and 45. History: Cr. Register, October, 1973, No. 214, eff. 11−1−73. History: Cr. Register, February, 1976, No. 242, eff. 3−1−76.

CSB 2.04 Addition of amobarbital, pentobarbital, CSB 2.09 Additions to schedules IV and I. (1) ADDI- and secobarbital to schedule II; retention of certain TION OF SUBSTANCES TO SCHEDULE IV. Paragraphs forms of amobarbital, pentobarbital and secobarbital in (cm), (cn), (cp), (cr), (em) and (hm) of sub. (2), s. 161.20, Stats., schedule III. (1) Subsection (7) of s. 161.16, Stats., schedule schedule IV are hereby created to read: II is hereby created to read as follows: (cm) (7) Unless excepted under federal regulations or listed in (cn) another schedule, any material, compound, mixture, or prepara- (cp) Chlorazepate tion which contains any quantity of the following substances: (cr) (a) Amobarbital (em) (b) Pentobarbital (hm) (c) Secobarbital (2) ADDITION OF THE THIOPHENE ANALOG OF PHENCYCLIDINE TO (2) Paragraphs (m) and (n) of sub. (3), s. 161.18, Stats., sched- SCHEDULE I. Paragraph (u) of sub. (4), s. 161.14, Stats., schedule ule III, are hereby created to read as follows: I is hereby created to read: (m) Unless excepted under federal regulations, any compound, (u) Thiophene analog of phencyclidine mixture, or preparation containing amobarbital, secobarbital, (3) ADDITION OF TO SCHEDULE I. Subsection pentobarbital or any salt thereof and one or more other active (5) and par. (a) of s. 161.14, Stats., schedule I are hereby created medicinal ingredients which are not listed in any schedule. to read: (n) Unless excepted under federal regulations, any suppository (5) Depressants. Unless specifically excepted or unless listed dosage form containing amobarbital, secobarbital, pentobarbi- in another schedule, any material compound, mixture or prepara- tal, or any salt of any of these drugs and approved by the federal tion which contains any quantity of the following substances hav- food and drug administration for marketing only as a suppository. ing a depressant effect on the central nervous system, including Note: See Chapter 206, Laws of 1981 sections 30 and 37. its salts, , and salts of isomers whenever the existence of History: Cr. Register, July, 1974, No. 223, eff. 8−1−74. such salts, isomers and salts of isomers is possible within the spe- cific chemical designation: CSB 2.05 Addition of drotebanol to schedule I. The (a) Mecloqualone substance known as drotebanol is hereby added to s. 161.14, (4) ADDITION OF TO SCHEDULE I. Paragraph (hg) of Stats., schedule I in sub. (3), par. (hm), which paragraph is created sub. (2), s. 161.14, Stats., schedule I is hereby created to read: to read: (hg) Difenoxin (hm) Drotebanol; (5) ADDITION OF 2,5 , 4−ROMO−2,5 History: Cr. Register, July, 1974, No. 223, eff. 8−1−74. DIMETHOXYAMPHETAMINE AND 4−METHOXYAMPHETAMINE TO SCHEDULE I. Paragraphs (v), (w) and (x) of sub. (4), s. 161.14, CSB 2.06 Addition of pentazocine to schedule III. Stats., schedule I are hereby created to read: Subsection (4m) of s. 161.18, Stats., schedule III is hereby created (v) 2,5−dimethoxyamphetamine to read as follows: (w) 4−bromo−2,5−dimethoxyamphetamine (4m) Pentazocine. (x) 4−methoxyamphetamine Note: See Chapter 6, Laws of 1981 sections 2 and 3. Note: See Chapter 206, Laws of 1981 sections 13 and 15. History: Cr. Register, August, 1974, No. 224, eff. 9−1−74. History: Cr. Register, April, 1976, No. 244, eff. 5−1−76. CSB 2.07 Transfer of hydrochloride form of etor- CSB 2.10 Addition of propiram to schedule I. Para- phine from schedule I to schedule II. (1) Subsection (3) graph (wn) of sub. (2), s. 161.14, Stats., schedule I is hereby cre- (intro.) of s. 161.14, Stats., schedule I is amended to read: ated to read: (3) Unless specifically excepted or listed in another schedule, (wn) Propiram any of the following opium derivatives, their salts, isomers and History: Cr. Register, August, 1976, No. 248, eff. 9−1−76. salts of isomers whenever the existence of these salts, isomers, and salts of isomers is possible within the specific chemical designa- CSB 2.11 Renumbering and addition to schedule IV tion: of diethylpropion and phentermine. Paragraph (a) of sub. (2) Paragraph (em) of sub. (3), s. 161.16, Stats., schedule II, (2m), s. 161.20, Stats., schedule IV is hereby renumbered to read: is hereby created to read: (b) Fenfluramine (em) Etorphine hydrochloride; Paragraph (a) of sub. (2m), s. 161.20, Stats., schedule IV is Note: See Chapter 206, Laws of 1981 sections 6, 20 and 24. hereby created to read: History: Cr. Register, August, 1974, No. 224, eff. 9−1−74. (a) Diethylpropion Paragraph (b) of sub. (2m), s. 161.20, Stats., schedule IV is CSB 2.08 Addition of poppy straw to schedule II, hereby renumbered to read: addition of pemoline and mebutamate to schedule IV. (c) Pemoline (1) Paragraph (d) of sub. (2), s. 161.16, Stats., schedule II is Paragraph (d) of sub. (2m), s. 161.20, Stats., schedule IV is hereby created to read: hereby created to read:

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each Register July 2021 No. 787 page is the date the chapter was last published. Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

3 CONTROLLED SUBSTANCES BOARD CSB 2.21

(d) Phentermine (mg) Prazepam; History: Cr. Register, August, 1976, No. 248, eff. 9−1−76. (4) Paragraph (hg) of s. 161.20 (2), Stats., is created to read: (hg) ; CSB 2.13 Addition of dextropropoxyphene to schedule IV. Subsection (4), s. 161.20, Stats., schedule IV is (5) Paragraph (mm) of s. 161.20 (2), Stats., is created to read: hereby created to read: (mm) ; (4) Other substances. Unless specifically excepted or unless (6) Paragraph (km) of s. 161.18 (3), Stats., is created to read: listed in another schedule, any material, compound, mixture or (km) and or any salt thereof; preparation which contains any quantity of the following sub- (7) Paragraph (a) of s. 161.16 (3), Stats., is renumbered to stances, including its salts: read: (a) Dextropropoxyphene (Alpha−(+)−4−dimethylamino−1, (am) Alphaprodine; 2−diphenyl−3−methyl−2−propionoxybutane) (8) Paragraph (a) of s. 161.16 (3), Stats., is created to read: Note: See Chapter 206, Laws of 1981 section 51. (a) ; History: Cr. Register, November, 1977, No. 263, eff. 12−1−77. (9) Paragraph (rg) of s. 161.14 (2), Stats., is created to read: CSB 2.14 Addition of prazepam to schedule IV. Para- (rg) MPPP 1−methyl−4−phenyl−4−propionoxypiperidine); graph (km), sub. (2), s. 161.20, Stats., schedule IV is hereby cre- (10) Paragraph (vg) of s. 161.14 (2), Stats., is created to read: ated to read: (vg) (PEPAP) 1−(2−phenethyl)−4−phenyl−4−acetoxypiperi- (km) Prazepam dine; History: Cr. Register, November, 1977, No. 263, eff. 12−1−77. (11) Paragraph (b) of s. 161.16 (10), Stats., is created to read: CSB 2.15 Addition of parahexyl to schedule I; (b) (another name for nabilone: (+)−trans−3− removal of loperamide from schedule V; addition of tria- (1,1−dimethylheptyl)−6, 6a, 7, 8, 10, 10a−hexahydro−1− zolam to schedule IV. (1) Paragraph (mn) of sub. (4), s. hydroxy−6, 6−dimethyl−9H−dibenzo [b,d] pyran−9−one). 161.14, Stats., is created to read: (12) Subsection (2) of s. 161.14, Stats., is amended to read: (mn) Parahexyl (2) . Unless specifically excepted under federal regu- (2) Paragraph (a) of sub. (3), s. 161.22, Stats., is repealed. lations or unless listed in another schedule, any of the following opiates, or their isomers, , ethers, salts, salts of isomers, (3) Paragraph (nm) of sub. (2), s. 161.20, Stats., is created to esters of ethers, if isomers, esters, ethers, salts or salts of isomers read: exist within the specified chemical designation (for purposes of (nm) Triazolam par. (tg) only, the term includes the optical and geometric History: Cr. Register, October, 1984, No. 346, eff. 11−1−84. isomers): CSB 2.16 Transfer of sufentanil from schedule I to (13) Paragraph (a) of s. 161.14 (2), Stats., is renumbered to schedule II. (1) Section 161.14 (2) (xg), Stats., is repealed. read: (2) Section 161.16 (3) (y), Stats., is created to read: (ag) ; (y) Sufentanil (14) Paragraph (a) of s. 161.14 (2), Stats., is created to read: History: Cr. Register, October, 1984, No. 346, eff. 11−1−84. (a) Acetyl−alpha−methylfentanyl (N−(1−(1−methyl−2−phene- thyl)−4−piperidinyl]−N−phenylacetamide); CSB 2.17 Addition of buprenorphine to schedule V; (15) Paragraph (cg) of s. 161.14 (2), Stats., is created to read: transfer of methaqualone from schedule II to schedule (cg) Alpha−methylthiofentanyl (N−[1−methyl−2−(2−thie- I; transfer of dronabinol from schedule I to schedule II. nyl)ethyl−4−piperidinyl]−N−phenylpropanamide); (2) Paragraph (b) of s. 161.14 (5), Stats., is adopted to read: (b) Methaqualone (16) Paragraph (dg) of s. 161.14 (2), Stats., is created to read: (dg) Beta−hydroxyfentanyl (N−[1−(2−hydroxy−2−phenethyl) (3) Subsection (7) (am) of s. 161.16, Stats., is repealed. −4−piperidinyl]−N−phenylpropanamide); (4) Subsection (10) (a) of s. 161.16, Stats., is created to read: (17) Paragraph (rj) of s. 161.14 (2), Stats., is created to read: (10) Hallucinogenic substances. (a) Dronabinol (synthetic) in (rj) 3−methylthiofentanyl (N−[3−methyl−1−(2−thienyl) sesame oil and encapsulated in a soft gelatin capsule in a U.S. ethyl−4−piperidinyl]−N−phenylpropanamide); food and drug administration approved drug product. (Other names for dronabinol are (6a R − trans) − 6a, 7, 8, 10a − tetra- (18) Paragraph (tg) of s. 161.14 (2), Stats., is created to read: hydro − 6, 6, 9 − trimethyl − 3 −pentyl−6H−dibenzo (b, d) pyran (tg) Para−fluorofentanyl (N−(4−fluorophenyl)−N−[1− − 1 − ol, or (−) − delta − 9 − (trans) − .) (2−phenethyl)−4−piperidinyl]propanamide); History: Cr. Register, August, 1986, No. 368, eff. 9−1−86; CR 03−056: r. (1) Reg- (19) Paragraph (xm) of s. 161.14 (2), Stats., is created to read: ister January 2004 No. 577, eff. 2−1−04. (xm) (N−phenyl−N−[1−(2−thienyl)ethyl−4−pip- CSB 2.18 Addition of 3,4−methylenedioxymetham- eridinyl]propanamide); phetamine to schedule I. Paragraph (am) of s. 161.14 (4), History: Cr. Register, February, 1988, No. 386, eff. 3−1−88. Stats., is created to read: CSB 2.20 Addition of beta−hydroxy−3−methylfen- (am) 3, 4−methylenedioxymethamphetamine, commonly tanyl to schedule I. Paragraph (er) of s. 161.14 (2), Stats., is known as“MDMA”; created to read: History: Cr. Register, September, 1987, No. 381, eff. 10−1−87. (er) Beta−hydroxy−3−methylfentanyl. History: Cr. Register, July, 1989, No. 403, eff. 8−1−89. CSB 2.19 Additions, deletions and transfers to stat- utory schedules. (1) Paragraph (b) of s. 161.20 (4), Stats., is CSB 2.21 Additions, deletions, corrections, trans- created to read: fers, and amendments to drug schedules. (1) Subsection (b) Not more than 25 milligrams per dosage unit of pentazocine (1) of s. 161.14, Stats., is amended to read: with one or more active, non− ingredients in recognized (1) Included substances. Unless specifically excepted by state therapeutic amounts. or federal law or regulation or more specifically included in (2) Paragraph (b) of s. 161.18 (4), Stats., is repealed. another schedule, the following controlled substances are listed (3) Paragraph (km) of s. 161.20 (2), Stats., is renumbered to in schedule I. read: (2) Paragraph (a) of s. 161.14 (2), Stats., is amended to read:

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published. Register July 2021 No. 787 Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

CSB 2.21 WISCONSIN ADMINISTRATIVE CODE 4

(a) Acetyl−alpha−methylfentany (N−[1−(1−methyl−2−pheny- (27) Subsection (9) of s. 161.16, Stats., is repealed. lethyl)−4−piperidinyl]−N−phenylacetamide); (28) Subsection (20m) of s. 161.01, Stats., is created to read: (3) Paragraph (er) of s. 161.14 (2), Stats., is amended to read: (20m) (a) “” means any drug or hormonal (er) Beta−hydroxy−3−methylfentanyl (N−[1−(2−hydroxy−2− substance, chemically or pharmacologically related to testoster- phenylethyl)−3−methyl−4−piperidinyl]−N−phenylpropana- one (except estrogens, progestin, and corticosteroids), that pro- mide); motes muscle growth. The term includes all of the substances (4) Paragraph (rg) of s. 161.14 (2), Stats., is amended to read: listed in s. 161.18 (7), and their esters, isomers, esters of isomers, (rg) MPPP (1−methyl−4−phenyl−4−propionoxypiperidine); salts and salts of esters, isomers and esters of isomers, that are theoretically possible under the specific chemical designation, (5) Paragraph (qs) of s. 161.14 (2), Stats., is amended to read: and if such esters, isomers, esters of isomers, salts and salts of (qs) 3−methylfentanyl (N−[3−methyl−1−(2−phenylethyl)−4− esters, isomers and esters of isomers promote muscle growth. piperidinyl]−N−phenylpropanamide); (b) Except as provided in par. (c), the term does not include an (6) Paragraph (tg) of s. 161.14 (2), Stats., is amended to read: anabolic steroid which is expressly intended for administration (tg) Para−fluorofentanyl (N−[1−(2−phenylethyl)−4−piperi- through implants to cattle or other nonhuman species and which dinyl]−N−(4−fluorophenyl)propanamide); has been approved by the United States secretary of health and (7) Paragraph (vg) of s. 161.14 (2), Stats., is amended to read: human services for such administration. (vg) PEPAP (1−(2−phenylethyl)−4−phenyl−4−acetoxypiperi- (c) If a person prescribes, dispenses or distributes such steroid dine); for human use, such person shall be considered to have pre- (8) Paragraph (xm) of s. 161.14 (2), Stats., is amended to read: scribed, dispensed or distributed an anabolic steroid within the (xm) Thiofentanyl (N−[1−(2−thienyl)ethyl−4−piperidinyl]−N− meaning of par. (a). phenylpropanamide); (29) Subsection (7) of s. 161.18, Stats., is created to read: (9) Paragraph (cd) of s. 161.14 (2), Stats., is created to read: (7) Anabolic steroids. Any material, compound, mixture, or (cd) Alpha−methylfentanyl (N−[1−(1−methyl−2−phenyl- preparation containing any quantity of the following anabolic ethyl)−4−piperidinyl]−N−phenylpropanamide); steroids, including any of their esters, isomers, esters of isomers, (10) Paragraph (e) of s. 161.14 (3), Stats., is amended to read: salts and salts of esters, isomers and esters of isomers, whenever (e) −N−oxide; those esters, isomers, esters of isomers, salts and salts [of] esters, isomers and esters of isomers exist within the specific chemical (11) Paragraph (j) of s. 161.14 (3), Stats., is amended to read: designation: (j) Etorphine, except its hydrochloride salts; (a) Boldenone; (12) Paragraph (s) of s. 161.14 (3), Stats., is amended to read: (b) 4−chlorotestosterone, which is also called clostebol; (s) −N−oxide; (c) Dehydrochloromethyltestosterone; (13) Paragraph (a) of s. 161.14 (4), Stats., is amended to read: (d) 4−, which is also called stanolone; (a) 3,4−methylenedioxyamphetamine, commonly known as (e) Drostanolone; “MDA”; (f) Ethylestrenol; (14) Paragraph (b) of s. 161.14 (4), Stats., is amended to read: (g) Fluoxymesterone; (b) 5−methoxy−3,4−methylenedioxyamphetamine; (h) Formebulone, which is also called fromebolone; (15) Paragraph (c) of s. 161.14 (4), Stats., is amended to read: (i) Mesterolone; (c) 3,4,5−; (j) Methandienone, which is also called methandrostenolone; (16) Paragraph (ag) of s. 161.14 (4), Stats., is created to read: (k) Methandriol; (ag) 3,4−methylenedioxyethylamphetamine, commonly known (l) Methenolone; as “MDE”; (m) Methyltestosterone; (17) Paragraph (ar) of s. 161.14 (4), Stats., is created to read: (n) Mibolerone; (ar) N−hydroxy−3,4−methylenedioxyamphetamine; (o) ; (18) Paragraph (u) of s. 161.14 (4), Stats., is amended to read: (p) Norethandrolone; (u) 1−[1−(2−thienyl)cyclohexyl]piperidine, which is the thio- (q) ; phene analog of phencyclidine; (r) Oxymesterone; (19) Paragraph (ud) of s. 161.14 (4), Stats., is created to read: (s) Oxymetholone; (ud) 1−[1−(2−thienyl)cyclohexyl]pyrrolidine, which is the (t) Stanozolol; thiophene pyrrolidine analog of phencyclidine; (u) Testolactone; (20) Paragraph (ur) of s. 161.14 (4), Stats., is amended to read: (v) ; (ur) 1−(1−phenylcyclohexyl)pyrrolidine, which is the pyrroli- (w) Trenbolone. dine analog of phencyclidine; (30) Paragraphs (ar), (av), (cd), (cg), (co), (cq), (cu), (ed), (21) Paragraph (d) of s. 161.14 (7), Stats., is created to read: (eg), (ej), (ep), (es), (eu), (ey), (hh), (hj), (hk), (hr), (md) and (ng) (d) 4−methylaminorex, including its salts and salts of isomers; of s. 161.20 (2), Stats., are created to read: (22) Paragraph (e) of s. 161.14 (7), Stats., is created to read: (ar) ; (e) N,N−, including its salts and salts of (av) ; isomers. (cd) ; (23) Paragraph (L) of s. 161.14 (7), Stats., is created to read: (cg) ; (L) , including its salts and salts of isomers. (co) ; (24) Subdivision 4m of s. 161.16 (2) (a), Stats., is created to (cq) ; read: (cu) ; 4m. ; (ed) ; (25) Paragraph (d) of s. 161.16 (3), Stats., is repealed. (eg) ; (26) Paragraph (am) of s. 161.16 (7), Stats., is created to (ej) ; read: (ep) ; (am) ; (es) ;

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each Register July 2021 No. 787 page is the date the chapter was last published. Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

5 CONTROLLED SUBSTANCES BOARD CSB 2.32

(eu) ; addition of fenproporex, modafinil, sibutramine, zale- (ey) ; plon and zolpidem to schedule IV; spelling correction of (hh) ; carfentanil. (1) Section 961.16 (3) (cm), Stats., is amended to (hj) ; read: (hk) Nordiazepam; (cm) Carfentanil; (hr) ; (2) Section 961.16 (3) (xm), Stats., is created to read: (md) ; (xm) Remifentanil; (ng) . (3) Section 961.16 (10) (a), Stats., is repealed. (31) Paragraph (eq) of s. 161.20 (2), Stats., is repealed and (4) Section 961.18 (4m), Stats., is created to read: recreated to read: (4m) Hallucinogenic substances. Dronabinol (synthetic) in (eq) sesame oil and encapsulated in a soft gelatin capsule in a U.S. (32) Paragraph (o) of s. 161.20 (2), Stats., is repealed. food and drug administration approved drug product. (Other (33) Paragraphs (ag), (ar) and (bm) of s. 161.20 (2m), Stats., names for dronabinol are (6aR−trans)−6a, 7, 8, 10a−tetrahy- are created to read: dro−6, 6. 9−trimethyl−3−pentyl−6H−dibenzo(b, d)pyran−1−ol, (ag) N,N−dimethyl−1,2−diphenylethylamine, commonly and (−)−delta−9−(trans)−tetrahydrocannabinol.) known as “SPA”; (5) Section 961.20 (2) (o) and (p), Stats., is created to read: (ar) Fencamfamine; (o) Zaleplon. (bm) Mazindol; (p) Zolpidem. (34) Paragraph (b) of s. 161.20 (4), Stats., is repealed and rec- (6) Section 961.20 (2m) (at), (bu) and (f), Stats., is created to reated to read: read: (b) Pentazocine, including its isomers and salts of isomers. (at) Fenproporex. History: Cr. Register, November, 1992, No 443, eff. 12−1−92. (bu) Modafinil. (f) Sibutramine. CSB 2.22 Additions to drug schedules. (1) Para- History: Cr. Register, July, 2000, No. 535, eff. 8−1−00. graph (b) of s. 161.14 (2), Stats., is amended to read: (b) (except Levo−alphacetylmethadol CSB 2.26 Addition of dihydroetorphine to schedule (LAAM)) II. (1) Section 961.16 (2) (a) 4r., Stats., is created to read: (2) Paragraph (cm) of s. 161.14 (4), Stats., is created to read: 4r. Dihydroetorphine. (cm) Alpha−ethyltryptamine, its optical isomers, salts and History: CR 01−071: Cr. Register November 2001 No. 551, eff. 12−1−01. salts of isomers; (3) Paragraph (bm) of s. 161.14 (4), Stats., is created to read: CSB 2.28 Addition of dichloralphenazone to sched- (bm) 2,5−dimethoxy−4−ethylamphetamine, commonly known ule IV. (1) Section 961.20 (2) (cs), Stats., is created to read: as DOET; Section 961.20 (2) (cs) Dichloralphenazone; History: CR 02−025: Cr. Register October 2002 No. 562, eff. 11−1−02. (4) Paragraph (am) of s. 161.14 (7), Stats., is created to read: (am) , its salts, optical isomers, and salts of optical CSB 2.29 Transfer of buprenorphine from schedule isomers; V to schedule III. (1) Section 961.18 (5m), Stats., is created to (5) Paragraph (ag) of s. 161.14 (7), Stats., is created to read: read: (ag) ; Section 961.18 (5m) NARCOTIC DRUGS NOT LIMITED BY QUAN- (6) Paragraph (gm) of s. 161.16 (3), Stats., is created to read: TITY. Any material, compound, mixture, or preparation containing (gm) Levo−alphacetylmethadol (LAAM) any of the following narcotic drugs, including any of their salts, History: Cr. Register, August, 1994, No. 464, eff. 9−1−94. isomers and salts of isomers that are theoretically possible within the specific chemical designation: CSB 2.23 Additions and amendments to drug (a) Buprenorphine schedules. (1) Paragraph (wg) of s. 161.14 (4), Stats., is cre- History: CR 03−056: cr. Register January 2004 No. 577, eff. 2−1−04. ated to read: (wg) 4−bromo−2,5−dimethoxyphenethylamine; CSB 2.30 Addition of gamma−hydroxybutyric acid (2) Subsection (7) (intro.) of s. 161.17, Stats., is amended to to schedule III. (1) Section 961.18 (3) (o), Stats., is created to read: read: (7) Anabolic steroids. Unless specifically excepted under fed- Section 961.18 (3) (o) Any drug product containing gamma− eral regulations, any compound, material, compound, mixture or hydroxybutyric acid, including its salts, isomers, and salts of iso- preparation containing any quantity of the following anabolic mers, for which an application is approved under section 505 of steroids, including any of their esters, isomers, esters of isomers, the federal food, drug and cosmetic act: salts and salts of esters, isomers and esters of isomers, whenever 1. Gamma−hydroxybutyric acid. those esters, isomers, esters of isomers, salts and salts [of] esters, History: CR 03−057: cr. Register January 2004 No. 577, eff. 2−1−04. isomers and esters of isomers exist within the specific chemical designation: CSB 2.31 Addition of 2,5 dimethoxy−4−(n)− propyl- (3) Paragraph (3) (c), of s. 161.18, Stats., is repealed. thiophenethylamine (2C−T−7) to schedule I. (1) Section History: Cr. Register, November, 1994, No. 467, eff. 12−1−94. 961.14 (4) (wh), Stats., is created to read: Section 961.14 (4) (wh) 2,5 dimethoxy−4−(n)− propylthiophe- CSB 2.24 Addition of butorphanol to schedule IV. nethylamine, commonly known as “2C−T−7”; (1) Paragraph (c) of s. 961.20 (4), Stats., is created to read: History: CR 06−058: cr. Register April 2007 No. 616, eff. 5−1−07. (c) Butorphanol, including any of its isomers and salts of iso- mers. CSB 2.32 Addition of N− benzylpiperazine (BZP) to History: Cr. Register, November, 1998, No. 515, eff. 12−1−98. schedule I. (1) Section 961.14 (7) (q), Stats., is created to read: Section 961.14 (7) (q) N− benzylpiperazine, commonly known CSB 2.25 Addition of remifentanil to schedule II; as “BZP.” transfer of dronabinol from schedule II to schedule III; History: CR 06−058: cr. Register April 2007 No. 616, eff. 5−1−07.

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published. Register July 2021 No. 787 Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

CSB 2.33 WISCONSIN ADMINISTRATIVE CODE 6

CSB 2.33 Addition of alpha−methyltryptamine 961.14 (2) (eu) Beta−hydroxythiofentanyl (AMT) to schedule I. (1) Section 961.14 (4) (wi), Stats., is cre- (N−[1−[2−hydroxy−2−(thiophen−2−yl)ethyl]piperi- ated to read: din−4−yl]−N−phenylpropionamide) Section 961.14 (4) (wi) Alpha−methyltryptamine, commonly (ey) Butyryl fentanyl (N−(1−phenethylpiperi- known as “AMT”; din−4−yl)−N−phenylbutyramide) History: CR 06−059: cr. Register April 2007 No. 616, eff. 5−1−07. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register August 2016 No. 728, eff. 7−18−16; CR 16−081: cr. Register July 2017 No. 739, eff. 8−1−17. CSB 2.34 Addition of 5−methoxy−N, N−diisopropyl- (5−MeO−DIPT). (1) Section 961.14 (4) (wj), CSB 2.42 Scheduling of furanyl fentanyl. Section Stats., is created to read: 961.14 (2) (ne) is created to read: Section 961.14 (4) (wj) 5−methoxy−N, N−diisopropyltrypta- 961.14 (2) (ne) Furanyl fentanyl (N−phenyl−N−[1−(2−phenyl- mine, commonly known as “5−MeO−DIPT”; ethyl)piperidin−4−yl]furan−2−carboxamide). History: CR 06−059: cr. Register April 2007 No. 616, eff. 5−1−07. History: EmR1626: emerg. cr., eff. 9−1−16; CR 16−059: cr. Register May 2017 No. 737, eff. 6−1−17. CSB 2.35 Addition of lisdexamfetamine to schedule II. (1) Section 961.16 (5) (e), Stats., is created to read: CSB 2.43 Addition of brivaracetam to schedule V. Section 961.22 (6), Stats., is created to read: Section 961.16 (5) (e) Lisdexamfetamine, commonly known as “Vyvanse TM.” 961.22 (6) BRIVARACETAM. Brivaracetam History: CR 10−112: cr. Register April 2011 No. 664, eff. 5−1−11. ((2S)−2−[(4R)−2−oxo−4−propylpyrrolidin−1−yl]butanamide), including its salts, isomers or salts of isomers. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Septem- CSB 2.36 Addition of tramadol to schedule IV. Sec- ber 2016 No. 729, eff. 9−26−16; CR 17−009: cr. Register July 2017 No. 739, eff. tion 961.20 (4) (e), Stats., is created to read: 8−1−17. Section 961.20 (4) (e) Tramadol, including any of its isomers and salts of isomers. CSB 2.44 Addition of thiafentanil to schedule II. Sec- History: cr. Affirmative action order under s. 968.11 (4), Stats., Register August tion 961.16 (3) (zx), Stats., is created to read: 2014 No. 704, eff. 9−1−14; CR 15−008: cr. Register October 2015 No. 718, eff. 11−1−15. 961.16 (3) (zx) Thiafentanil. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October 2016 No. 730, eff. 10−3−16; CR 17−007: cr. Register July 2017 No. 739, eff. 8−1−17. CSB 2.37 Rescheduling of hydrocodone combina- tion products. Sections 961.18 (5) (c) and (d), Stats., are CSB 2.45 Addition of AB−FUBINACA and ADB− repealed. PINACA to schedule I. Section 961.14 (4) (tb) 32. and 33., History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October 2014 No. 706, eff. 11−1−14; CR 15−007: cr. Register October 2015 No. 718, eff. Stats., is created to read: 11−1−15. 961.14 (4) (tb) 32. N−(1−amino−3−methyl−1−oxobu- tan−2−yl)−1−(4−fluorobenzyl)−1H−indazole−3−carboxamide, CSB 2.38 Addition of suvorexant to schedule IV. commonly known as AB−FUBINACA. Section 961.20 (2) (mr), Stats., is created to read: 33. N−(1−amino−3,3−dimethyl−1−oxobutan−2−yl)−1−pen- Section 961.20 (2) (mr) Suvorexant. tyl−1H−indazole−3−carboxamide, commonly known as ADB− History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October PINACA. 2014 No. 706, eff. 11−1−14; CR 15−009: cr. Register October 2015 No. 718, eff. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October 11−1−15. 2016 No. 730, eff. 10−10−16; CR 17−008: cr. Register July 2017 No. 739, eff. 8−1−17. CSB 2.39 Exclusion of naloxegol. Section 961.16 (2) (a) (intro.), Stats., is amended to read: CSB 2.46 Addition of acetyl fentanyl to schedule I. 961.16 (2) (a) (intro) Opium and substances derived from Section 961.14 (2) (ae), Stats., is created to read: opium, and any salt, compound, derivative or preparation of 961.14 (2) (ae) Acetyl fentanyl opium or substances derived from opium. , dextror- (N−(1−phenethylpiperidin−4−yl)−N−phenylacetamide). phan, , butorphanol, , naloxegol, History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- and and their respective salts and the isoquinoline ber 2016 No. 731, eff. 11−21−16; CR 17−021: cr. Register November 2017 No. 743, eff. 12−1−17. alkaloids of opium and their respective salts are excluded from this paragraph. The following substances, and any of their salts, CSB 2.47 Addition of AH−7921 to schedule I. Section isomers and salts of isomers that are theoretically possible within 961.14 (2) (aj), Stats., is created to read: the specific chemical designation, are included in this paragraph: History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 961.14 (2) (aj) AH−7921 (3,4−dichloro−N−[(1−dimethyl- 2015 No. 711B, eff. 4−1−15; CR 15−068: cr. Register August 2016 No. 728, eff. amino)cyclohexylmethyl]). 9−1−16. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- ber 2016 No. 731, eff. 11−21−16; CR 17−023: cr. Register November 2017 No. 743, CSB 2.40 Exclusion of [123I]ioflupane. Section 961.16 eff. 12−1−17. (2) (b), Stats., is amended to read: CSB 2.48 Addition of eluxadoline to schedule IV. (b) leaves and any salt, compound, derivative or prepa- Section 961.20 (4) (cm), Stats., is created to read: ration of coca leaves. Decocainized coca leaves or extractions which do not contain or ecgonine are excluded from this 961.20 (4) (cm) Eluxadoline, including any of its isomers, and paragraph. [123I]Ioflupane is excluded from this paragraph. The salts of isomers. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- following substances and any of their salts, esters, isomers and ber 2016 No. 731, eff. 11−21−16; CR 17−022: cr. Register November 2017 No. 743, salts of esters and isomers that are theoretically possible within eff. 12−1−17. the specific chemical designation, are included in this paragraph: History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October CSB 2.49 Addition of U−47700 to schedule I. Section 2015 No. 718A3, eff. 10−19−15; correction made under s. 35.17, Stats., Register 961.14 (2) (z), Stats., is created to read: October 2015 No. 718; CR 16−060: cr. Register May 2017 No. 737, eff. 6−1−17. 961.14 (2) (z) U−47700 (3,4−dichloro−N−[2−(dimethyl- CSB 2.41 Scheduling of beta−hydroxythiofentanyl amino)cyclohexyl]−N−methylbenzamide). History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Decem- and butyryl fentanyl. Sections 961.14 (2) (eu) and (ey) are cre- ber 2016 No. 732, eff. 12−19−16; CR 17−020: cr. Register November 2017 No. 743, ated to read: eff. 12−1−17.

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each Register July 2021 No. 787 page is the date the chapter was last published. Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

6−1 CONTROLLED SUBSTANCES BOARD CSB 2.63

CSB 2.50 Addition of AB−CHMINACA, AB−PINACA CSB 2.56 Addition of 4−fluoroisobutyryl fentanyl to and THJ−2201 to schedule I. Section 961.14 (4) (tb) 34., 35., schedule I. Section 961.14 (2) (nc), Stats., is created to read: and 36., Stats., are created to read: 961.14 (2) (nc) 4−fluoroisobutyryl fentanyl (N−(4−fluoro- 961.14 (4) (tb) 34. N−(1−amino−3−methyl−1−oxobu- phenyl)−N−(1−phenethylpiperidin−4−yl)isobutyramide); tan−2−yl)−1−(cyclohexylmethyl)−1H−indazole−3−carboxamide, History: cr. Affirmative action order under s. 961.11 (4), Stats., Register June commonly known as AB−CHMINACA. 2017 No. 738, eff. 6−12−17. 35. N−(1−amino−3−methyl−1−oxobutan−2−yl)−1−pen- tyl−1H−indazole−3−carboxamide, commonly known as AB− CSB 2.57 Scheduling of cyclopropyl fentanyl. Sec- PINACA). tion 961.14 (2) (nd) 10d., Stats., is created to read: 36. [1−(5−fluoropentyl)−1H−indazol−3−yl](naph- 961.14 (2) (nd) 10d. Cyclopropyl fentanyl thalen−1−yl)methanone, commonly known as THJ−2201. (N−(1−phenethylpiperidin−4−yl)−N−phenylcyclopropanecar- History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April boxamide); 2017 No. 736, eff. 3−27−17; correction in (intro.) made under s. 35.17, Stats., Reg- History: EmR 1716: emerg. cr. eff. 9−8−17; CR 17−0785: cr. Register July 2018 ister April 2017 No. 736. No. 751, eff. 8−1−18; corrections made under s. 35.17, Stats., Register July 2018 No. 751. CSB 2.51 Addition of MAB−CHMINACA to schedule I. Section 961.14 (4) (tb) 37., Stats., is created to read: CSB 2.58 Exclusion of naldemedine. Section 961.16 (2) (a) (intro), Stats., is amended to read: 961.14 (4) (tb) 37. N−(1−amino−3,3−dimethyl−1−oxobu- tan−2−yl)−1−(cyclohexylmethyl)−1H−indazole−3−carboxamide, 961.16 (2) (a) (intro) Opium and substances derived from commonly known as MAB−CHMINACA or ADB−CHMINACA. opium, and any salt, compound, derivative or preparation of History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April opium or substances derived from opium. Apomorphine, dextror- 2017 No. 736, eff. 3−27−17. phan, nalbuphine, butorphanol, naldemedine, nalmefene, naloxe- gol, naloxone and naltrexone and their respective salts and the CSB 2.52 Addition of 4−MePPP and a−PBP to isoquinoline alkaloids of opium and their respective salts are schedule I. Section 961.14 (7) (L) 32. and 33., Stats., is created excluded from this paragraph. The following substances, and any to read: of their salts, isomers and salts of isomers that are theoretically 961.14 (7) (L) 32. 4−methyl−alpha−pyrrolidinopropiophe- possible within the specific chemical designation, are included in none, commonly known as 4−MePPP. this paragraph: 33. Alpha−pyrrolidinobutiophenone, commonly known as History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- ber 2017 No. 743, eff. 11−20−17; CR 18−024: cr. Register June 2019 No. 762, eff. a−PBP. 7−1−19. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register April 2017 No. 736, eff. 4−10−17. CSB 2.59 Addition of ortho−fluorofentanyl to CSB 2.53 Scheduling of acryl fentanyl. Section schedule I. Section 961.14 (2) (nd) 16m., Stats., is created to 961.14 (2) (ai), Stats., is created to read: read: 961.14 (2) (ai) Acryl fentanyl (N−phenyl−N−[1−(2−phenyl- 961.14 (2) (nd) 16m. Ortho−fluorofentanyl (N−(2−fluoro- ethyl)piperidin−4−yl]−2−propenamide); phenyl)−N−(1−phenethylpiperidin−4−yl)propionamide); History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Decem- Note: Section 961.14 (2) (ai), Stats., was renumbered to s. 961.14 (2) (nd) 3. by ber 2017 No. 744, eff. 12−4−17; correction made under s. 35.17, Stats., Register 2017 Wis. Act 60. December 2017 No. 744; CR 18−023: cr. Register June 2019 No. 762, eff. 7−1−19. History: EmR1710: emerg. cr., eff. 5−2−17; CR 17−040: cr. Register November 2017 No. 743, eff. 12−1−17; correction made under s. 35.17, Stats., Register Novem- ber 2017 No. 743. CSB 2.60 Addition of FUB−AMB to schedule I. Sec- tion 961.14 (4) (tb) 43., Stats., is created to read: CSB 2.54 Addition of oral solutions containing dro- 961.14 (4) (tb) 43. methyl 2−(1−(4−fluorobenzyl)−1H−inda- nabinol to schedule II. Section 961.16 (10), Stats., is created zole−3−carboxamido)−3−methylbutanoate, commonly known as to read: FUB−AMB, MMB−FUBINACA or AMB−FUBINACA. 961.16 (10) (a) Dronabinol [(−)−delta−9−trans−tetrahydro- History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Decem- ber 2017 No. 744, eff. 12−11−17; correction made under s. 35.17, Stats., Register (delta−9−THC)] in an oral solution in a drug product December 2017 No. 744; CR 18−022: cr. Register June 2019 No. 762, eff. 7−1−19. approved by the U.S. food and drug administration. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2017 No. 737, eff. 5−15−17; CR 18−055: cr. Register June 2019 No. 762, eff. 7−1−19. CSB 2.61 Addition of MT−45 to schedule I. Section 961.14 (2) (rk), Stats., is created to read: CSB 2.55 Addition of 5F−ADB, 5F−AMB, ADB− 961.14 (2) (rk) MT−45 (1−cyclo- FUBINACA, MDMB−CHMICA and MDMB−FUBINACA to hexyl−4−(1,2−diphenylethyl)); schedule I. Section 961.14 (4) (tb) 38., 39., 40., 41., and 42., History: cr. Affirmative action order under s. 961.11 (4), Stats., Register January 2018 No. 745, eff. 1−22−18; correction made under s. 35.17, Stats., Register January Stats., is created to read: 2018 No. 745; CR 18−069: cr. Register June 2019 No. 762, eff. 7−1−19. 961.14 (4) (tb) 38. Methyl 2−(1−(5−fluoropentyl)−1H−inda- zole−3−carboxamido)−3,3−dimethylbutanoate, commonly CSB 2.62 Addition of para−chloroisobutyryl fenta- known as 5F−ADB. nyl to schedule I. Section 961.14 (2) (nd) 16s., Stats., is created 39. Methyl 2−(1−(5−fluoropentyl)−1H−indazole−3−car- to read: boxamido)−3−methylbutanoate, commonly known as 5F−AMB. 961.14 (2) (nd) 16s. Para−chloroisobutyryl fentanyl 40. N−(1−amino−3,3−dimethyl−1−oxobutan−2−yl)−1−(4−flu- (N−(4−chlorophenyl)−N−(1−phenethylpiperidin−4−yl)isobutyra- orobenzyl)−1H−indazole−3−carboxamide, commonly known as mide); ADB−FUBINACA. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 41. Methyl 2−(1−(cyclohexylmethyl)−1H−indole−3−car- 2018 No. 747, eff. 3−12−18; CR 18−070: cr. Register June 2019 No. 762, eff. 7−1−19. boxamido)−3,3−dimethylbutanoate commonly known as MDMB− CHMICA. CSB 2.63 Addition of NM2201, 5F−AB−PINACA, 4−CN−CUMYL−BUTINACA, MMB−CHMICA and 42. Methyl 2−(1−(4−fluorobenzyl)−1H−indazole−3−car- 5F−CUMYL−P7AICA to schedule I. Section 961.14 (4) (tb) boxamido)−3,3−dimethylbutanoate, commonly known as 44., 45., 46., 47., and 48., Stats., are created to read: MDMB−FUBINACA. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 961.14 (4) (tb) 44. Naphthalen−1−yl 1−(5−fluoropen- 2017 No. 737, eff. 5−15−17. tyl)−1H−indole−3−carboxylate, commonly known as NM2201.

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published. Register July 2021 No. 787 Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

CSB 2.63 WISCONSIN ADMINISTRATIVE CODE 6−2

45. N−(1−amino−3−methyl−1−oxobutan−2−yl)−1−(5−fluoro- 36. Alpha−pyrrolidinohexanophenone, commonly known as pentyl)−1H−indazole−3−carboxamide, commonly known as a−PHP. 5F−AB−PINACA. 37. 4−methyl−alpha−ethylainopentiophenone, commonly 46. 1−(4−cyanobutyl)−N−(2−phenylpropan−2−yl)−1H−inda- known as 4−MEAP. zole−3−carboxamide, commonly known as 4−CN−CUMYL− 38. 4’−methyl−alpha−pyrrolidinohexiophenone, commonly BUTINACA. known as MPHP. 47. Methyl 2−(1−(cyclohexylmethyl)−1H−indole−3−car- 39. Alpha−pyrrolidinoheptaphenone, commonly known as boxamido)−3−methylbutanoate, commonly known as MMB− PV8. CHMICA. 40. 4’−chloro−alpha−pyrrolidinovalerophenone, commonly 48. 1−(5−fluoropentyl)−N−(2−phenylpropan−2−yl)−1H−pyr- known as 4−chloro−a−PVP. rolo[2,3−b]pyridine−3−carboxamide, commonly known as History: cr. Affirmative action order under s. 961.11 (4g), Stats., Register August 5F−CUMYL−P7AICA. 2019 No. 764, eff. 8−19−19; CR 20−050: cr. Register June 2021 No. 786, eff. 7−1−21. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 2018 No. 747, eff. 3−12−18; cr. Affirmative action order under s. 961.11 (4), Stats., CSB 2.69 Addition of Noroxymorphone to schedule Register August 2018 No. 752, eff. 8−13−18; correction made under s. 35.17, Stats., II. Section 961.16 (2) (a) 10m., Stats., is created to read: Register August 2018 No. 752; CR 19−010: cr. Register June 2020 No. 774, eff. 961.16 (2) (a) 10m. Noroxymorphone. 7−1−20; correction made under s. 35.17, Stats., Register June 2021 No. 786. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- ber 2019 No. 767, eff. 11−11−19; CR 20−051: cr. Register June 2021 No. 786, eff. CSB 2.64 Addition of N−Ethylpentylone to schedule 7−1−21. I. Section 961.14 (7) (L) 34., Stats., is created to read: 961.14 (7) (L) 34. N−Ethylpentylone, commonly known as CSB 2.70 Scheduling 4F−MDMB−BINACA and ephylone. MMB−FUBICA. Section 961.14 (4) (tb) 38m. and 43m., Stats., History: cr. Affirmative action order under s. 961.11 (4), Stats., Register October are created to read: 2018 No. 754, eff. 10−1−18; CR 19−011: cr. Register June 2020 No. 774, eff. 7−1−20. 961.14 (4) (tb) 38m. Methyl 2−(1−(4−fluorobutyl)−1H−inda- zole−3−carboxamido)−3,3−dimethylbutanoate, commonly CSB 2.65 Addition of approved cannabidiol drugs known as 4F−MDMB−BINACA or 4F−MDMB−BUTINACA. to schedule V. Section 961.22 (7), Stats., is created to read: 43m. Methyl 2−(1−(4−fluorobenzyl)−1H−indole−3−car- 961.22 (7) Approved cannabidiol drugs. A drug product in fin- boxamido)−3−methylbutanoate, commonly known as MMB− ished dosage formulation that has been approved by the United FUBICA or AMB−FUBICA. States food and drug administration that contains cannabidiol History: EmR2017: emerg. cr., eff. 6−26−20; CR 20−022: cr. Register May 2021 (2−[1R−3−methyl−6R−(1−methylethenyl)−2−cyclo- No. 785, eff. 6−1−21. hexen−1−yl]−5−pentyl−1,3−benzenediol) derived from CSB 2.71 Addition of lasmiditan to schedule V. Sec- and no more than 0.1 percent (w/w) residual tetrahydrocannabi- tion 961.22 (8), Stats., is created to read: nols. History: cr. Affirmative action order under s. 961.11 (4g), Stats., Register October 961.22 (8). Lasmiditan [2,4,6−trifluoro− 2018 No. 754, eff. 10−15−18; CR 19−012: cr. Register June 2020 No. 774, eff. N−(6−(1−methylpiperidine−4−carbonyl)pyridine−2−yl−benz- 7−1−20. amide]. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March CSB 2.66 Addition of 5F−EDMB−PINACA, 2020 No.771, eff. 3−23−20; CR 20−058: cr. Register July 2021 No. 787, eff. 5F−MDMB−PICA, FUB−AKB48, 5F−CUMYL−PINACA, 8−1−21. and FUB−144 to schedule I. Section 961.14 (4) (tb), 49., 50., CSB 2.72 Scheduling of isotonitazene and 1P−LSD. 51., 52., and 53., Stats., are created to read: Section 961.14 (2) (pe) and (4) (jm), Stats., are created to read: 961.14 (4) (tb) 49. Ethyl 2−(1−(5−fluoropentyl)−1H−inda- 961.14 (2) (pe) Isotonitazene; zole−3−carboxamido)−3,3−dimethylbutanoate, commonly known 961.14 (4) (jm) 1−propionyl−lysergic acid diethylamide, com- as 5F−EDMB−PINACA. monly known as 1P−LSD; 50. Methyl 2−(1−(5−fluoropentyl)−1−indole−3−car- History: EmR2013: emerg. cr., eff. 6−5−20; CR 20−023: cr. Register May 2021 No. 785, eff. 6−1−21; correction made under s. 35.17, Stats., Register May 2021 No. boxamido)−3,3−dimethylbutanoate, commonly known as 785. 5F−MDMB−PICA. 51. N−(adamantan−1−yl)−1−(4−fluorobenzyl)−1H−inda- CSB 2.73 Addition of cenobamate to schedule V. zole−3−carboxamide, commonly known as FUB−AKB48, FUB− Section 961.22 (9), Stats., is created to read: APINACA or AKB48 N−(4−FLUOROBENZYL). 961.22 (9) CENOBAMATE Cenobamate ([(1R)−1−(2−chloro- 52. 1−(5−fluoropentyl)−N−(2−phenylpropan−2−yl)−1H−inda- phenyl)−2−(tetrazol−2−yl)ethyl] ; 2H−tetra- zole−3−carboxamide, commonly known as 5F−CUMYL− zole−2−ethanol, alpha−(2−chlorophenyl)−, carbamate (), PINACA or SGT−25. (alphaR)−; (R)−(+)−1−(2−chloro- 53. (1−(4−fluorobenzyl)−1H−indol−3−yl)(2,2,3,3−tetramethyl- phenyl)−2−(2H−tetrazol−2−yl)ethyl ester) cyclopropyl)methanone, commonly known as FUB−144. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May 2020 No. 773, eff. 5−18−20; CR 20−075: cr. Register July 2021 No. 787, eff. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 8−1−21. 2019 No. 759, eff. 3−11−19; CR 20−048: cr. Register June 2021 No. 786, eff. 7−1−21. CSB 2.74 Addition of Lemborexant to schedule IV. CSB 2.67 Addition of Brexanolone and Solriamfetol Section 961.20 (2) (eqm), Stats., is created to read: to schedule IV. Section 961.20 (2) (ap) and (2m) (g), Stats., are 961.20 (2) (eqm) Lemborexant. created to read: History: cr. Affirmative action order under s. 961.11 (4), Stats., Register March 961.20 (2) (ap) Brexanolone; 2020 No.771, eff. 5−18−20; CR 20−076: cr. Register July 2021 No. 787, eff. (2m) (g) Solriamfetol. 8−1−21; correction made under s. 35.17, Stats., Register July 2021 No. 787. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2019 No. 763, eff. 7−22−19; CR 20−049: cr. Register June 2021 No. 786, eff. 7−1−21; cor- CSB 2.75 Exclusion of approved cannabidiol drugs rection in (2) (ap) made under s. 35.17, Stats., Register June 2021 No. 785. from schedule I. (1) Section 961.14 (4) (t) 4., Stats., is created to read: CSB 2.68 Addition of N−Ethylhexedrone, a−PHP, 961.14 (4) (t) 4. A drug product in finished dosage formulation 4−MEAP, MPHP, PV8 and 4−chloro−a−PVP to schedule that has been approved by the United States food and drug admin- I. Section 961.14 (7) (L) 35. to 40., Stats., is created to read: istration that contains cannabidiol 961.14 (7) (L) 35. N−Ethylhexedrone. (2−[1R−3−methyl−6R−(1−methylethenyl)−2−cyclo-

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each Register July 2021 No. 787 page is the date the chapter was last published. Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

6−3 CONTROLLED SUBSTANCES BOARD CSB 2.89

hexen−1−yl]−5−pentyl−1,3−benzenediol) derived from cannabis 24. N−phenyl−N−(1−(2−phenylpropyl)piperidin−4−yl)propi- and no more than 0.1 percent (w/w) residual tetrahydrocannabi- onamide (b−methyl fentanyl); nols. 25. N−(2−fluoro- (2) Section 961.22 (7) is repealed. phenyl)−N−(1−phenethylpiperidin−4−yl)butyramide (ortho−flu- History: cr. Affirmative action order under s. 961.11 (4g), Stats., Register June orobutyryl fentanyl; 2−fluorobutyryl fentanyl); 2020 No. 774, eff. 6−29−20; CR 20−077: cr. Register July 2021 No. 787, eff. 8−1−21. 26. N−(2−methyl- phenyl)−N−(1−phenethylpiperidin−4−yl)acetamide (ortho− CSB 2.76 Addition of norfentanyl to schedule II. methyl ; 2−methyl acetylfentanyl); (1) Section 961.16 (8) (b), Stats., is renumbered 961.16 (8) (b) 27. 2−methoxy−N−(2−methyl- (intro.) and amended to read: phenyl)−N−(1−phenethylpiperidin−4−yl)acetamide (ortho− 961.16 (8) (b) An immediate precursor to fentanyl, including methyl ; 2−methyl methoxyacetyl fenta- all of the following: nyl); 1. 4−anilino−N−phenethyl−4−piperidine, commonly known as 28. N−(4−methyl- ANPP. phenyl)−N−(1−phenethylpiperidin−4−yl)propionamide (para− (2) Section 961.16 (8) (b) 2., Stats. is created to read: methylfentanyl; 4−methylfentanyl); 2. N−phenyl−N−(piperidin−4−yl)propionamide, commonly 29. N−(1−phenethylpiperidin−4−yl)−N−phenylbenzamide known as norfentanyl. (phenyl fentanyl; benzoyl fentanyl); History: cr. Affirmative action order under s. 961.11 (4), Stats., Register June 30. N−(1−phenethylpiperidin−4−yl)−N−phenylthio- 2020 No. 774, eff. 6−29−20; CR 20−078: cr. Register July 2021 No. 787, eff. phene−2−carboxamide (thiofuranyl fentanyl; 2−thiofuranyl fen- 8−1−21. tanyl; thiophene fentanyl). History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July CSB 2.77 Scheduling of flualprazolam. Section 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July 961.20 (2) (ef), Stats., is created to read: 2021 No. 787. 961.20 (2) (ef) Flualprazolam; History: EmR1037: emerg. cr., eff. 10−27−20; CR 20−078: cr. Register July CSB 2.84 Addition of alfaxalone to schedule IV. 2021 No. 787, eff. 8−1−21; correction made under s. 35.17, Stats., Register July (1) Section 961.20 (2) (a), Stat., is repealed and recreated to read: 2021 No. 787. 961.20 (2) (a) Alfaxalone; CSB 2.78 Addition of crotonyl fentanyl to schedule (2) Section 961.20 (2) (ak) is created to read: I. Section 961.14 (2) (nd) 9m., Stats., is created to read: 961.20 (2) (ak) ; 961.14 (2) (nd) 9m. Crotonyl Fentanyl History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7−19−21; correction in numbering made under s. 13.92 (4) (b) ((E)−N−(1−phenethylpiperidin−4−yl)−N−phenylbut−2− enam- 1, Stats., and correction made under s. 35.17, Stats., Register July 2021 No. 787. ide); History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- ber 2020 No. 779, eff. 11−23−20. CSB 2.85 Excluding 6−beta−naltrexol from sched- ule II. Section 961.16 (2) (a), Stats., is amended to read: CSB 2.79 Addition of remimazolam to schedule IV. 961.16 (2) (a) Opium and substances derived from opium, and Section 961.20 (2) (mo), Stats., is created to read: any salt, compound, derivative or preparation of opium or sub- 961.20 (2) (mo) Remimazolam; stances derived from opium. Apomorphine, , nalbu- History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Novem- phine, butorphanol, naldemedine, nalmefene, naloxegol, nalox- ber 2020 No. 779, eff. 11−23−20. one, 6−beta−naltrexol, and naltrexone and their respective salts and the isoquinoline alkaloids of opium and their respective salts CSB 2.80 Addition of oliceridine to schedule II. Sec- are excluded from this paragraph. The following substances, and tion 961.16 (3) (ta), Stats., is created to read: any of their salts, isomers and salts of isomers that are theoreti- 961.16 (3) (ta) Oliceridine; cally possible within the specific chemical designation, are History: cr. Affirmative action order under s. 961.11 (4), Stats., Register Decem- ber 2020 No. 780, eff. 12−14−20. included in this paragraph: History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July CSB 2.81 Addition of brorphine to schedule I. Sec- 2021 No. 787. tion 961.14 (2) (et), Stats., is created to read: 961.14 (2) (et) Brorphine; CSB 2.86 Addition of fospropofol to schedule IV. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register May Section 961.20 (2) (en), Stats., is created to read: 2021 No. 785, eff. 4−26−21; correction made under s. 35.17, Stats., Register May 2021 No. 785. 961.20 (2) (en) Fospropofol; History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July CSB 2.82 Addition of Serdexmethylphenidate to 2021 No. 787. schedule IV. Section 961.20 (2m) (em), Stats., is created to read: 961.20 (2m) (em) Serdexmethylphenidate. CSB 2.87 Addition of embutramide to schedule III. History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7−12−21. Section 961.18 (3) (bm), Stats., is created to read: 961.18 (3) (bm) Embutramide; CSB 2.83 Addition of ten (10) fentanyl−related sub- History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July stances to schedule I. Section 961.14 (2) (nd) 21., 22., 23., 2021 No. 787. 24., 25., 26., 27., 28., 29., and 30., Stats., is created to read: 961.14 (2) (nd) 21. N−(1−(2−fluo- CSB 2.88 Addition of lacosamide to schedule V. rophenethyl)piperidin−4−yl)−N−(2−fluorophenyl)propionamide Section 961.22 (10), Stats., is created to read: (2’−fluoro ortho−fluorofentanyl; 2’−fluoro 2−fluorofentanyl); 961.22 (10) Lacosamide. 22. N−(1−(4−methylphenethyl)piperidin−4−yl)−N−phenyl- History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July acetamide (4’−methyl acetyl fentanyl); 2021 No. 787, eff. 7−19−21. 23. N−(1−phenethylpiperidin−4−yl)−N,3−diphenyl- propanamide (b’−phenyl fentanyl; beta’−Phenyl fentanyl; CSB 2.89 Addition of perampanel to schedule III. 3−phenylpropanoyl fentanyl); Section 961.18 (3) (fm), Stats., is created to read:

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each page is the date the chapter was last published. Register July 2021 No. 787 Published under s. 35.93, Wis. Stats., by the Legislative Reference Bureau.

CSB 2.89 WISCONSIN ADMINISTRATIVE CODE 6−4

961.18 (3) (fm) Perampanel; ated to read: History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July 961.16 (8) (c) Immediate precursors to phencyclidine, also 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July 2021 No. 787. known as PCP: 1. 1−phenylcyclohexylamine. CSB 2.90 Transfer of 1−phenylcyclohexylamine 2. 1−piperidinocyclohexanecarbonitrile. and 1−piperidinocyclohexanecarbonitrile, immediate History: cr. Affirmative action order under s. 961.11 (4), Stats., Register July precursors to phencyclidine, also known as PCP, from 2021 No. 787, eff. 7−19−21; correction made under s. 35.17, Stats., Register July Schedule I to schedule II. Section 961.16 (8) (c), Stats., is cre- 2021 No. 787.

Published under s. 35.93, Stats. Updated on the first day of each month. Entire code is always current. The Register date on each Register July 2021 No. 787 page is the date the chapter was last published.